Letter from the Editor: the tea leaves of innovation brewing in academia

As science marches on, it can be hard to know what’s at the forefront of translational research — specifically, what are the areas seeing a convergence of discoveries with commercial potential, and what do those trends tell you about where innovation is headed?

In a series of articles, Karen Tkach Tuzman, BioCentury’s Head of Discovery and Preclinical Research analysis, has delved into BioCentury’s Distillery to identify where academic translation in 2023 signaled the next spurts of innovation might lie...